{"transactions":[{"id":2155960,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-19T22:17:23.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":1452,"price":7.6585,"value":11120.142,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":121897,"source":{"system":"sec-edgar","filing":"0001209191-22-050613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122050613/doc4.xml","form_type":"4"}},{"id":2163258,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-08T21:53:47.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":89054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/36th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":89054,"derivative":{"exercise_price":7.14,"expiration_date":"2032-09-05","underlying":"Common Stock","underlying_shares":89054},"source":{"system":"sec-edgar","filing":"0001209191-22-049219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122049219/doc4.xml","form_type":"4"}},{"id":2163257,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-08T21:53:47.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":105000,"derivative":{"exercise_price":7.14,"expiration_date":"2032-09-05","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-22-049219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122049219/doc4.xml","form_type":"4"}},{"id":2163256,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-08T21:53:47.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":1800,"price":8.5255,"value":15345.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":120445,"source":{"system":"sec-edgar","filing":"0001209191-22-049219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122049219/doc4.xml","form_type":"4"}},{"id":2524780,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:59:06.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":7964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests based on achievement of a performance objective."}],"balance_after":7964,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":7964},"source":{"system":"sec-edgar","filing":"0001209191-21-063023","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063023/doc4.xml","form_type":"4"}},{"id":2524779,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:59:06.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":7964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests based on achievement of a performance objective."}],"balance_after":7964,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":7964},"source":{"system":"sec-edgar","filing":"0001209191-21-063023","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063023/doc4.xml","form_type":"4"}},{"id":2524778,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:59:06.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":83626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":83626,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":83626},"source":{"system":"sec-edgar","filing":"0001209191-21-063023","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063023/doc4.xml","form_type":"4"}},{"id":2566269,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A Preferred Stock","published_at":"2021-09-17T20:44:08.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":8183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21254},"source":{"system":"sec-edgar","filing":"0000899243-21-036427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089924321036427/doc4.xml","form_type":"4"}},{"id":2566268,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":88274,"kind":"person","name":"van den Boom Esther","position":1,"cik":"0001603563","reported_name":"van den Boom Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-17T20:44:08.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":21254,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member."}],"balance_after":21254,"source":{"system":"sec-edgar","filing":"0000899243-21-036427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089924321036427/doc4.xml","form_type":"4"}}]}